Clinical Trial Update: Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study [Phase 1]

View source ↗

Summary

Phase 1 intramuscular trial of allopregnanolone as a regenerative therapy for early Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: University of Arizona | Conditions: Alzheimer Dementia | Phase 1 | Status: TERMINATED